Skip to main content

People in the News: Jul 23, 2009

Premium

Biogen Idec announced that co-founder Phillip Sharp is retiring from the company's board of directors.

Sharp, a co-founder of Alnylam Pharmaceuticals, is currently a professor at the Massachusetts Institute of Technology. He received the Nobel Prize in medicine in 1993.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.